miR-27b synergizes with anticancer drugs via p53 activation and CYP1B1 suppression

Liver and kidney cancers are notorious for drug resistance. Due to the complexity, redundancy and interpatient heterogeneity of resistance mechanisms, most efforts targeting a single pathway were unsuccessful. Novel personalized therapies targeting multiple essential drug resistance pathways in para...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cell Res
Main Authors: Mu, Wenjing, Hu, Chaobo, Zhang, Haibin, Qu, Zengqiang, Cen, Jin, Qiu, Zhixin, Li, Chao, Ren, Haozhen, Li, Yixue, He, Xianghuo, Shi, Xiaolei, Hui, Lijian
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group 2015
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4387554/
https://ncbi.nlm.nih.gov/pubmed/25698578
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cr.2015.23
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados